GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Other Long Term Assets

Cangene (FRA:YGE) Other Long Term Assets : €27.08 Mil (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Other Long Term Assets?

Cangene's other long-term assets for the quarter that ended in Oct. 2013 was €27.08 Mil.

Cangene's quarterly other long-term assets declined from Apr. 2013 (€30.00 Mil) to Jul. 2013 (€27.78 Mil) but then stayed the same from Jul. 2013 (€27.78 Mil) to Oct. 2013 (€27.08 Mil).

Cangene's annual other long-term assets increased from Jul. 2011 (€22.87 Mil) to Jul. 2012 (€26.19 Mil) and increased from Jul. 2012 (€26.19 Mil) to Jul. 2013 (€27.78 Mil).


Cangene Other Long Term Assets Historical Data

The historical data trend for Cangene's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Other Long Term Assets Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 16.62 22.87 26.19 27.78

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.14 24.47 30.00 27.78 27.08

Cangene Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines